J. Vachiéry

发表

The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension

L. Beretta, J. Vachiéry, M. Vicenzi, 2022, PloS one.

Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta‐analysis

G. Parati, L. Badano, A. Bondue, 2022, ESC heart failure.

Echocardiography in pulmonary arterial hypertension.

J. Vachiéry, P. Forfia, J. Vachiéry, 2012, The American journal of cardiology.

Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation.

R. Naeije, J. Vachiéry, S. Caravita, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

CASE ANECDOTES, COMMENTS AND OPINIONS

R. Naeije, S. Caravita, G. Deboeck, 2016 .

Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung

C. Auffray, R. Slama, J. Vincent, 2017, The Journal of allergy and clinical immunology.

T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase‐9 via a C‐C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction

J. Vincent, Y. Castier, A. Didier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation

R. Slama, Y. Castier, J. Pellet, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Relation of coronary hypersensitivity to serotonin in cardiac transplant recipients to vessel wall morphology and effect of vitamin C.

M. Goldman, O. Pradier, J. Vachiéry, 2006, The American journal of cardiology.

Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.

D. Renlund, J. Copeland, M. Carrier, 1999, Transplantation.

Determinants of right ventricular failure after heart transplantation.

M. Leeman, J. Vachiéry, M. Van Cutsem, 1996, Acta cardiologica.

Plasma endothelin and early coronary endothelial dysfunction in recipients of a cardiac transplant.

J. Vachiéry, G. Berkenboom, M. Antoine, 1995, American heart journal.

The endothelin system in pulmonary and renal vasculopathy: les liaisons dangereuses

J. Vachiéry, J. Vachiéry, A. Davenport, 2009, European Respiratory Review.

Ambulatory management of primary pulmonary hypertension

J. Vachiéry, 2000 .

Pulmonary hypertension due to left heart disease

S. Rosenkranz, M. Guazzi, J. Vachiéry, 2019, European Respiratory Journal.

Exercise-induced pulmonary hypertension: physiological basis and methodological concerns.

R. Naeije, G. Lewis, R. Saggar, 2013, American journal of respiratory and critical care medicine.

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

Fach, Thilo, D. DeMets, 1999, The Lancet.

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

Fach, Thilo, D. DeMets, 1999, The Lancet.

Exercise echocardiography in pulmonary hypertension

J. Vachiéry, A. Pavelescu, J. Vachiéry, 2007 .

Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.

J. Barberà, H. Ghofrani, A. Frost, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research.

R. Wachter, S. Rosenkranz, M. Guazzi, 2016, European heart journal.

Treatment of pulmonary arterial hypertension in Eisenmenger syndrome: Practice makes (almost) perfect.

J. Vachiéry, J. Vachiéry, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pulmonary Arterial Hypertension Management – A New Approach For a Rare Disease

J. Vachiéry, 2016 .

Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.

D. Renlund, J. Copeland, M. Carrier, 1999, Transplantation.

INCREASED SYMPATHETIC NERVE ACTIVITY IN PRIMARY PULMONARY HYPERTENSION: P1.167

P. Borne, R. Naeije, J. Degaute, 2004 .

Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study.

E. Mahmud, A. Kirtane, M. Leon, 2020, JACC. Cardiovascular interventions.

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.

M. Humbert, G. Meszaros, S. Rosenkranz, 2022, European heart journal.

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

M. Humbert, G. Meszaros, S. Rosenkranz, 2022, European Respiratory Journal.

Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure

R. Naeije, J. Vachiéry, I. Lang, 2017, Circulation. Heart failure.

Absence of L-arginine effect on coronary hypersensitivity to serotonin in cardiac transplant recipients.

J. Vachiéry, G. Berkenboom, V. Crasset, 1999, The American journal of cardiology.

Endothelial function of internal mammary artery in patients with coronary artery disease and in cardiac transplant recipients.

J. Vachiéry, G. Berkenboom, V. Crasset, 1998, American heart journal.

Does third generation left ventricular assist device alter heart failure-related microvascular dysfunction?

P. van de Borne, J. Argacha, J. Vachiéry, 2016, Acta cardiologica.

The Belgian Eisenmenger syndrome registry: Implications for treatment strategies?

M. de Pauw, W. Budts, R. Naeije, 2009, Acta cardiologica.

Pulmonary hypertension due to left heart disease: diagnostic value of pulmonary artery distensibility

B. Gerber, P. Gevenois, E. Coche, 2020, European Radiology.

Bosentan reverses the hypoxia-induced downregulation of the bone morphogenetic protein signaling in pulmonary artery smooth muscle cells.

R. Naeije, J. Vachiéry, M. Remmelink, 2016, Life sciences.

Controversies in pulmonary hypertension due to left heart disease

J. Vachiéry, J. Vachiéry, M. Cheli, 2015, F1000prime reports.

Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader.

G. Parati, L. Badano, C. Baratto, 2021, Circulation. Heart failure.

Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: bias and error

G. Parati, A. Bondue, G. Branzi, 2019, European Respiratory Journal.

Pulmonary hypertension in chronic lung diseases.

F. Martinez, W. Seeger, J. Barberà, 2013, Journal of the American College of Cardiology.

Haemodynamic response to dynamic exercise after heart-lung transplantation.

M. Estenne, J. Vachiéry, G. Niset, 1999, The European respiratory journal.

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH

H. Gall, N. Tanabe, E. Grünig, 2018, Lung.

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

J. Barberà, H. Ghofrani, A. Frost, 2015, Annals of the rheumatic diseases.

Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.

J. Barberà, S. Rosenkranz, H. Ghofrani, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Transition from intravenous epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension

R. Barst, R. Naeije, N. Hill, 2002 .

Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension.

R. Barst, R. Naeije, N. Hill, 2002, Chest.

Erratum : 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

G. Hansmann, M. Humbert, A. Torbicki, 2015 .

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey

M. Humbert, D. Montani, C. Belge, 2020, ERJ Open Research.

Beyond the World Symposium on Pulmonary Hypertension: practical management of pulmonary arterial hypertension and evolving concepts

N. Galiè, J. Vachiéry, 2019, European heart journal supplements : journal of the European Society of Cardiology.

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.

M. Humbert, J. Barberà, S. Rosenkranz, 2020, Respiratory medicine.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Simon Gibbs, Patrizio Lancellotti, Theresa McDonagh, 2015, European Respiratory Journal.

Unbowed, unbent, unbroken: predicting pulmonary hypertension using echocardiography

J. Vachiéry, A. Vonk-Noordegraaf, Mariëlle C. van de Veerdonk, 2022, European Respiratory Journal.

Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component

G. Parati, R. Naeije, A. Bondue, 2017, PloS one.

Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations

R. Naeije, E. Grunig, R. Vanderpool, 2012, European Respiratory Journal.

Iron deficiency is associated with adverse outcome in Eisenmenger patients.

M. de Pauw, W. Budts, R. Naeije, 2011, European heart journal.

Kcnk3 Dysfunction Exaggerates The Development Of Pulmonary Hypertension Induced By Left Ventricular Pressure Overload.

M. Humbert, M. Ghigna, F. Perros, 2021, Cardiovascular research.

Sildenafil improves renal function in patients with pulmonary arterial hypertension.

D. Webb, J. Vachiéry, L. Hwang, 2015, British journal of clinical pharmacology.

nternational Guidelines for the Selection of Lung Transplant andidates : 2006 Update — A Consensus Report From the ulmonary Scientific Council of the International Society or Heart and Lung Transplantation

P. Corris, M. Estenne, S. Nathan, 2006 .

The linear relationship between systolic pulmonary artery pressure and mean pulmonary artery pressure is maintained regardless of autonomic or rhythm disturbances

J. Racapé, J. Vachiéry, T. Bové, 2016, Respiratory Research.

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry.

M. Humbert, J. Barberà, S. Rosenkranz, 2020, Respiratory medicine.

Early‐onset and severe pulmonary arterial hypertension due to a novel compound heterozygous association of rare VHL mutations: A case report and review of existing data

G. Smits, A. Bondue, J. Vachiéry, 2022, Pulmonary circulation.

A novel metrics to predict right heart failure after left ventricular assist device implantation

J. Vachiéry, C. Dewachter, C. Stefanidis, 2021, Journal of Artificial Organs.

Clearing Our Vision for Discerning Precapillary From Postcapillary Pulmonary Hypertension With the OPTICS Risk Score

M. Simon, J. Vachiéry, J. Vachiéry, 2020, Journal of the American Heart Association.

Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis

G. Parati, A. Bondue, J. Vachiéry, 2018, European Respiratory Journal.

NYHA Functional Class II: An Achievable Goal for All Patients with Pulmonary Arterial Hypertension Receiving Treatment

V. McLaughlin, J. Vachiéry, S. Gibbs, 2009 .

International, Prospective Registry For The Documentation Of First-line And Maintenance Therapy In Patients With Pulmonary Hypertension (CompERA-XL): Aims, Design, Methods, And Baseline Characteristics Of Patients

H. Ghofrani, M. Hoeper, C. Vizza, 2010, ATS 2010.

Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics

G. Filippatos, A. Mebazaa, F. Ruschitzka, 2022, European journal of heart failure.

Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm.

J. Vincent, J. Vachiéry, S. Wan, 1996, The Annals of thoracic surgery.

High-Altitude–Induced Right-Heart Failure

R. Naeije, J. Vachiéry, J. Martinot, 2007 .

Practical recommendations on the use of echocardiography to assess pulmonary arterial hypertension - a Belgian expert consensus endorsed by the Working Group on Non-Invasive Cardiac Imaging

J. De Sutter, J. Voigt, L. Badano, 2013 .

Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension

R. Naeije, P. van de Borne, J. Vachiéry, 2004, Circulation.

Initial combination therapy with ambrisentan (AMB) and tadalafil (TAD) in treatment naïve patients with pulmonary arterial hypertension (PAH): Efficacy and safety in the AMBITION study intent to treat (ITT) population

J. Barberà, A. Frost, G. Simonneau, 2015 .

Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension

R. Naeije, M. Remmelink, L. Dewachter, 2014 .

Response to the letter "Pulmonary artery wedge pressure and exercise oscillatory ventilation in pre-capillary pulmonary hypertension".

R. Naeije, M. Vicenzi, G. Deboeck, 2016, International journal of cardiology.

Guidelines for the diagnosis and treatment of pulmonary hypertension

G. Filippatos, P. Vardas, M. Humbert, 2009 .

Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial

R. Naeije, G. Layton, J. Vachiéry, 2010 .

Pulmonary hypertension due to left heart diseases.

F. Martinez, W. Seeger, J. Barberà, 2013, Journal of the American College of Cardiology.

Acute Hemodynamic Effects of Single‐Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS‐1 Study

C. Vizza, E. Michelakis, J. Vachiéry, 2009, Journal of clinical pharmacology.

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

J. Barberà, S. Rosenkranz, G. Simonneau, 2017, BMC Pulmonary Medicine.

Right ventricular function in patients with Eisenmenger syndrome.

J. Voigt, M. de Pauw, W. Budts, 2012, The American journal of cardiology.

Images in cardiovascular medicine. High-altitude-induced right-heart failure.

R. Naeije, J. Vachiéry, J. Martinot, 2007, Circulation.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

J. Barberà, H. Ghofrani, A. Frost, 2015, The New England journal of medicine.

Impact of COVID‐19 lockdown on exercise capacity in PAH patients

G. Parati, A. Bondue, J. Vachiéry, 2022, Pulmonary circulation.

Challenges in the diagnosis and treatment of pulmonary arterial hypertension

J. Vachiéry, S. Gaine, J. Vachiéry, 2012, European Respiratory Review.

Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.

J. Vincent, M. Goldman, A. Marchant, 1996, The Journal of thoracic and cardiovascular surgery.

Bretylium tosylate versus lidocaine in experimental cardiac arrest.

J. Vincent, J. Vachiéry, S. Blecic, 1990, American Journal of Emergency Medicine.

An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease

G. Parati, A. Bondue, J. Vachiéry, 2022, Pulmonary circulation.

Oxygenation improvement with nitric oxide in right-to-left shunt without significant effects on pulmonary arterial pressure.

J. Vincent, D. De Backer, R. Kahn, 1996, Chest.

Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study.

R. Naeije, G. Derumeaux, J. Vachiéry, 2005, American journal of physiology. Heart and circulatory physiology.

Gastric perforation due to mucormycosis after heart-lung and heart transplantation.

M. Estenne, M. Struelens, F. Jacobs, 1998, Transplantation.

International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

F. Martinez, P. Corris, J. Egan, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Simon Gibbs, Patrizio Lancellotti, Theresa McDonagh, 2016, Revista espanola de cardiologia.

Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.

J. Vachiéry, D. de Cannière, G. Berkenboom, 1994, American heart journal.

The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease

R. Naeije, R. Vanderpool, J. Vachiéry, 2012, European Respiratory Journal.

Management of severe pulmonary arterial hypertension

G. Simonneau, J. Vachiéry, J. Vachiéry, 2010, European Respiratory Review.

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Simon Gibbs, Patrizio Lancellotti, Theresa McDonagh, 2015, Kardiologia polska.

Left ventricular heart failure and pulmonary hypertension

R. Wachter, S. Rosenkranz, J. Vachiéry, 2015, European heart journal.

Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.

R. Naeije, J. Vachiéry, M. Remmelink, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pulmonary hypertension due to left heart diseases.

F. Martinez, W. Seeger, J. Barberà, 2013, Journal of the American College of Cardiology.

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.

M. Humbert, A. Torbicki, R. Naeije, 2002, Journal of the American College of Cardiology.

Macitentan in pulmonary hypertension due to left ventricular dysfunction

M. Hutyra, L. Rubin, J. Vachiéry, 2018, European Respiratory Journal.

Physiological response to the six-minute walk test in pulmonary arterial hypertension

R. Naeije, J. Vachiéry, J. Moraine, 2005, European Respiratory Journal.

Living with pulmonary hypertension: unique insights from an international ethnographic study

J. Vachiéry, B. Hinzmann, M. Kingman, 2014, BMJ Open.

Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension

L. Sharples, C. Mélot, R. Naeije, 2012, European Respiratory Journal.

How to detect disease progression in pulmonary arterial hypertension

J. Vachiéry, S. Huez, J-L Vachiéry, 2012, European Respiratory Review.

Screening for pulmonary arterial hypertension in systemic sclerosis

J. Vachiéry, G. Coghlan, J. Vachiéry, 2009, European Respiratory Review.

Worsening in oxygen saturation and exercise capacity predict adverse outcome in patients with Eisenmenger syndrome.

J. Voigt, M. de Pauw, W. Budts, 2013, International journal of cardiology.

Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction

G. Parati, M. Senni, L. Badano, 2021, Circulation. Heart failure.

A critical review on telemonitoring in heart failure

A. Pouleur, W. Mullens, W. Droogné, 2012, Acta cardiologica.

At high cardiac output, diesel exhaust exposure increases pulmonary vascular resistance and decreases distensibility of pulmonary resistive vessels.

P. van de Borne, J. Argacha, J. Vachiéry, 2015, American journal of physiology. Heart and circulatory physiology.

Physiological response to the 6-minute walk test in chronic heart failure patients versus healthy control subjects

R. Naeije, G. Deboeck, A. V. Muylem, 2014, European journal of preventive cardiology.

Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction

G. Parati, L. Badano, D. Muraru, 2023, Frontiers in Cardiovascular Medicine.

Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.

G. Parati, R. Naeije, A. Bondue, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.

J. Barberà, S. Rosenkranz, H. Ghofrani, 2016, The Lancet. Respiratory medicine.

Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy

J. Vachiéry, J. Vachiéry, 2011, Advances in therapy.

Treprostinil for pulmonary hypertension

R. Naeije, J. Vachiéry, J. Vachiéry, 2004, Expert review of cardiovascular therapy.

Practical recommendations on the use of echocardiography to assess pulmonary arterial hypertension--a Belgian expert consensus endorsed by the Working Group on Non-Invasive Cardiac Imaging.

J. De Sutter, J. Voigt, D. De Wolf, 2013, Acta cardiologica.

Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension.

R. Naeije, J. Vachiéry, S. Brimioulle, 2004, Chest.

Management of Pulmonary Hypertension in Left Heart Disease

J. Vachiéry, F. Macera, J. Vachiéry, 2021, Methodist DeBakey cardiovascular journal.

Pulmonary hypertension: the importance of correctly diagnosing the cause

J. Vachiéry, S. Mehta, J. Vachiéry, 2016, European Respiratory Review.

Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension.

M. Gómez-Sánchez, R. Naeije, J. Vachiéry, 2006, Chest.

Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study.

O. Sitbon, M. Hoeper, K. Olsson, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Interventional and surgical modalities of treatment for pulmonary arterial hypertension.

P. Corris, E. Trulock, W. Klepetko, 2004, Journal of the American College of Cardiology.

Robert Naeije and Philippe Van De Borne Increased Peripheral Chemoreceptors Sensitivity and Exercise Ventilation in Heart Increased Peripheral Chemoreceptors Sensitivity and Exercise Ventilation in Heart Transplant Recipients

J. Degaute, R. Naeije, P. van de Borne, 2022 .

Lung diffusion capacity correlates with pre‐implant pulmonary hypertension and predicts outcome after LVAD implantation

A. Bondue, J. Vachiéry, C. Dewachter, 2022, ESC heart failure.

Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung?

J. Vachiéry, S. Caravita, J. Vachiéry, 2016, Current Heart Failure Reports.

Update in treatment options in pulmonary hypertension.

M. Kanwar, T. Thenappan, J. Vachiéry, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.

R. Naeije, G. Layton, J. Vachiéry, 2011, British journal of clinical pharmacology.

Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.

M. Rubenfire, A. Torbicki, J. Behr, 2002, American journal of respiratory and critical care medicine.

A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities

J. Vachiéry, L. Dewachter, C. Dewachter, 2022, Frontiers in Cardiovascular Medicine.

Improvement in right ventricular function during reversibility testing in pulmonary arterial hypertension: a case report

R. Naeije, J. Vachiéry, S. Huez, 2009, Cardiovascular ultrasound.

Tissue Doppler imaging evaluation of cardiac adaptation to severe pulmonary hypertension.

R. Naeije, J. Vachiéry, S. Brimioulle, 2007, The American journal of cardiology.

Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension.

R. Naeije, P. van de Borne, J. Vachiéry, 2007, Chest.

Rehabilitation after Heart Transplantation Methodological Aspects and Results

J. Vachiéry, M. Lamotte, G. Niset, 1998 .

Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.

R. Naeije, J. Vachiéry, M. Vicenzi, 2016, International journal of cardiology.

Transitioning From IV Epoprostenol to Subcutaneous Treprostinil in Pulmonary Arterial Hypertension

R. Barst, R. Naeije, N. Hill, 2002 .

Assessment of coronary flow reserve by transesophageal echocardiography in cardiac transplant recipients.

P. Damhaut, J. Vachiéry, S. Goldman, 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.

M. Estenne, J. Vachiéry, C. Knoop, 1994, Transplantation proceedings.

Atrial septostomy under transesophageal guidance in a patient with primary pulmonary hypertension and absent right superior vena cava

D. Backer, P. Unger, E. Stoupel, 1996, Intensive Care Medicine.

[Pulmonary arterial hypertension].

J. Guiot, P. Lancellotti, J. Vachiéry, 2019, Revue medicale de Liege.

Right Heart Catheterization

J. Vachiéry, C. Dewachter, J. Vachiéry, 2018 .

Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries.

D. Wikler, P. Damhaut, J. Vachiéry, 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Coronary vasomotility and myocardial blood flow early after heart transplantation.

D. Wikler, P. Damhaut, J. Vachiéry, 1996, The American journal of cardiology.